Creatinine, a byproduct of muscle function, may be more sensitive in tracking SMA progression and response to treatment than ...

Positive results from its Phase III STEER study mean Novartis could boost sales of its OAV101 IT drug for spinal muscular ...

Investing.com -- Novartis AG (SIX:NOVN) has reported that an advanced study showed their new experimental drug improved motor function in children suffering from a form of spinal muscular atrophy. The ...

Investing.com -- Novartis AG (SIX:NOVN) has reported that an advanced study showed their new experimental drug improved motor function in children suffering from a form of spinal muscular atrophy.

The finding is particularly significant for those suffering from incomplete spinal ... show improvement, those with incomplete injuries (where some nerve pathways remain intact) demonstrated ...

—A new study analyzed health-related quality of life (HRQoL) using 5 generic and neuromuscular disease-specific rating scales in German children with spinal muscular atrophy (SMA), most of whom ...